CAT
Caterpillar Inc.
CAT has the edge over SEB overall, supported by stronger modeled upside and stronger fundamentals.
SEB
Seaboard Corporation
SEB offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
CAT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
CAT's revenue, profitability, cash flow and balance sheet are all currently healthy.
SEB Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Under pressure | |
| Healthy |
SEB's revenue, profitability and balance sheet are currently healthy, but its cash flow is under pressure.
CAT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $380 | -37% |
| Fair | 18x | $461 | -24% |
| Forward | 20x | $605 | — |
| Current | 24x | $605 | — |
| Expensive | 33x | $840 | +39% |
Historical ranges are pointers, not guarantees.
CAT's PE is in its expensive range at 24x. If earnings grow as analysts expect, today's price would be 20x next year's earnings, in its fair range.
SEB PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 6.4x | $3,703 | — |
| Cheap | 7.7x | $4,443 | +20% |
| Fair | 11x | $6,203 | +68% |
| Expensive | 27x | $15,382 | +315% |
Historical ranges are pointers, not guarantees.
SEB has the edge over CAT in the historical PE scenario, which offers more potential upside but is not a forecast.
CAT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Low |
Analysts expect earnings and revenue growth for CAT, with profitability improving. However, they disagree widely on these estimates.
SEB Forward outlook
There aren't enough analyst estimates for SEB to show an outlook.
CAT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $29.73 | +17% |
| Q3 2026 | $25.48 | +31% |
| Q2 2026 | $23.23 | +18% |
| Q1 2026 | $20.08 | -2% |
| Q4 2025 | $18.81 | -15% |
| Q3 2025 | $19.46 | -9.7% |
| Q2 2025 | $19.64 | -10% |
| Q1 2025 | $20.50 | -7.4% |
| Q4 2024 | $22.05 | +9.6% |
CAT earned $25.48 per share over the past year, up 31% from the year before.
SEB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $575.79 | +40% |
| Q2 2026 | $660.27 | +361% |
| Q1 2026 | $605.75 | +500% |
| Q4 2025 | $514.46 | +468% |
| Q3 2025 | $410.46 | +$421.16 |
| Q2 2025 | $143.31 | -43% |
| Q1 2025 | $100.91 | -57% |
| Q4 2024 | $90.62 | -54% |
SEB has the edge over CAT on earnings, with more consistent year-over-year improvement.
CAT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.7B | +17% |
| Q2 2026 | $20.5B | +24% |
| Q1 2026 | $17.4B | +22% |
| Q4 2025 | $19.1B | +18% |
| Q3 2025 | $17.6B | +9.5% |
| Q2 2025 | $16.6B | -0.7% |
| Q1 2025 | $14.2B | -9.8% |
| Q4 2024 | $16.2B | -5% |
CAT's revenue has grown year over year for five quarters in a row: $20.7B last quarter, up 17% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +3.1 points |
| Q2 2026 | 21% | +3.6 points |
| Q1 2026 | 18% | -0.4 points |
| Q4 2025 | 14% | -4.1 points |
| Q3 2025 | 17% | -2.2 points |
| Q2 2025 | 17% | -3.6 points |
| Q1 2025 | 18% | -4.2 points |
| Q4 2024 | 18% | -0.3 points |
CAT has the edge over SEB on profitability, with a higher operating margin.
SEB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $2.8B | +9.1% |
| Q2 2026 | $2.9B | +18% |
| Q1 2026 | $2.4B | +3.6% |
| Q4 2025 | $2.4B | -2.9% |
| Q3 2025 | $2.5B | +15% |
| Q2 2025 | $2.5B | +12% |
| Q1 2025 | $2.3B | +5.7% |
| Q4 2024 | $2.5B | +8.8% |
SEB's revenue is growing: $2.8B last quarter, up 9.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 0.5% | -2.8 points |
| Q2 2026 | 3.4% | +1.3 points |
| Q1 2026 | 4% | +2.4 points |
| Q4 2025 | 2.7% | -1.9 points |
| Q3 2025 | 3.3% | +1.9 points |
| Q2 2025 | 2.1% | +0.7 points |
| Q1 2025 | 1.6% | +2.5 points |
| Q4 2024 | 4.6% | +8.4 points |
SEB's operating margin was 0.5% last quarter, down 2.8 points from the same quarter a year ago.
CAT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +19% |
| Q2 2026 | $3.8B | +47% |
| Q1 2026 | $1.1B | +97% |
| Q4 2025 | $2.7B | +0.1% |
| Q3 2025 | $3.1B | -1.5% |
| Q2 2025 | $2.6B | -4.2% |
| Q1 2025 | $579M | -63% |
| Q4 2024 | $2.7B | -22% |
CAT has the edge over SEB on cash generation, producing positive trailing cash flow while its opponent burns cash.
SEB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $165M | +8.6% |
| Q2 2026 | -$78M | -$8M |
| Q1 2026 | -$150M | -$21M |
| Q4 2025 | $53M | -67% |
| Q3 2025 | $152M | +162% |
| Q2 2025 | -$70M | +$57M |
| Q1 2025 | -$129M | -$44M |
| Q4 2024 | $162M | +$195M |
SEB's free cash flow was −$10M over the past year, against $115M the year before.
CAT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -1.6M shares |
| 1 year | -2.1% | -9.9M shares |
| 3 years | -10% | -51.7M shares |
| 5 years | -16% | -86.7M shares |
| Available history | -19% | -107M shares |
CAT has the edge over SEB on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.2B |
| Q2 2026 | $1.5B |
| Q1 2026 | $5B |
| Q4 2025 | $340M |
| Q3 2025 | $362M |
| Q2 2025 | $828M |
| Q1 2025 | $3.7B |
| Q4 2024 | $640M |
CAT spent $8.1B buying back its own shares over the past year, up 47% from the year before.
SEB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | -0.1% | -824 shares |
| 3 years | -17% | -203K shares |
| 5 years | -17% | -203K shares |
| Available history | -18% | -208K shares |
SEB has 957,794 diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q4 2025 | $1M |
| Q3 2025 | $14M |
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | $13M |
| Q4 2019 | — |
CAT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | 2.0x | Healthy |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | 1.6x | Healthy |
CAT has the edge over SEB on leverage, with a lower net debt burden relative to earnings.
SEB Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.3x | Healthy |
| Q2 2026 | 1.2x | Healthy |
| Q1 2026 | 1.4x | Healthy |
| Q4 2025 | 1.4x | Healthy |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.7x | Healthy |
| Q4 2024 | 1.9x | Healthy |
SEB's net debt is about 1.3 years of its operating earnings (EBITDA), about the same as a year ago.
CAT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.7 | Neutral |
| Stochastic | 6.7 | Oversold |
CAT's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
SEB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.5 | Neutral |
| Stochastic | 20.5 | Neutral |
SEB's weekly RSI is 38 (neutral) and its Stochastic is 20 (neutral).
CAT PE vs Industrials Sector
| Metric | CAT | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 24x | 1.1% below |
| PE % | 69 | 58 | 11 pts above |
CAT is trading at 24x earnings, in line with the Industrials sector's median of 24x.
SEB PE vs Industrials Sector
| Metric | SEB | Sector median | Relative |
|---|---|---|---|
| PE | 6.4x | 24x | 73% below |
| PE % | 8 | 58 | 50 pts below |
SEB has the edge over CAT on valuation relative to its sector.
CAT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $709.0 | 15% below |
| 20 week MA | $797.0 | 24% below |
| 50 week MA | $771.3 | 22% below |
| 100 week MA | $586.7 | 3.2% above |
| 200 week MA | $443.1 | 37% above |
CAT has the edge over SEB on trend strength, trading above more of its moving averages.
SEB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3,862.2 | 4.1% below |
| 20 week MA | $4,161.7 | 11% below |
| 50 week MA | $4,677.4 | 21% below |
| 100 week MA | $3,866.3 | 4.2% below |
| 200 week MA | $3,649.8 | 1.5% above |
SEB has fallen below most of its moving averages, though it's still 1.5% above its 200-week average.
CAT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $148.3 | $179.6 | +21% |
| 2021 | $179.6 | $206.2 | +15% |
| 2022 | $206.2 | $239.9 | +16% |
| 2023 | $239.9 | $295.7 | +23% |
| 2024 | $295.7 | $364.9 | +23% |
| 2025 | $364.9 | $583.0 | +60% |
| 2026 YTD | $583.0 | $605.3 | +3.8% |
CAT has the edge over SEB on returns for 2026, with the stronger performance.
SEB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $4,169.5 | $3,107.0 | -25% |
| 2021 | $3,107.0 | $3,931.0 | +27% |
| 2022 | $3,931.0 | $3,710.0 | -5.6% |
| 2023 | $3,710.0 | $3,570.1 | -3.8% |
| 2024 | $3,570.1 | $2,407.7 | -33% |
| 2025 | $2,407.7 | $4,369.0 | +81% |
| 2026 YTD | $4,369.0 | $3,702.9 | -15% |
SEB has finished lower in four of the last six years. It's down 15% so far in 2026.